Aemetis, INC

Market Movers (8-K)

See all →
NASDAQ
Aemetis Inc. announced robust second quarter 2026 financial results, featuring a 20% year-over-year revenue increase to $62.7 million, driven by growth in its California Ethanol and Dairy RNG segments, alongside positive gross profit and a significant reduction in net loss.
Better than expected
Capital raise
NASDAQ
Aemetis, Inc. held its Annual Meeting of Stockholders on May 20, 2026, where Lydia I. Beebe was elected as a Class II director and KPMG LLP was ratified as the independent auditor.
NASDAQ
Aemetis announced first quarter 2026 financial results, showcasing a 27% year-over-year revenue increase to $54.6 million, a significant improvement in gross profit, and growth across its key business segments.
Capital raise
NASDAQ
Aemetis, Inc. announced the engagement of KPMG LLP as its new independent registered public accounting firm, replacing RSM US LLP, effective for the quarter ending March 31, 2026.
Worse than expected
NASDAQ
Aemetis reports strong Q4 2025 results driven by a 61% year-over-year increase in dairy RNG production and anticipates a $32 million annual cash flow boost from ethanol plant upgrades.
Better than expected
Delay expected
Capital raise
NASDAQ
Aemetis Biogas LLC secured an extension for its Series A Preferred Unit redemption, but faces a higher aggregate obligation and potentially costly debt terms.
Delay expected
Worse than expected
Capital raise

Quarterly Earnings (10-Q)

See all →
NASDAQ
Aemetis, Inc. reported increased revenues for Q2 2026 driven by its California Ethanol and RNG segments, but faces significant debt obligations and a going concern warning.
Worse than expected
Capital raise
NASDAQ
Aemetis, Inc. reported a 27.4% increase in total revenue for Q1 2026, driven by strong performance in its Renewable Natural Gas and India Biodiesel segments, though the company continues to face significant liquidity concerns and a substantial debt burden.
Capital raise
NASDAQ
Aemetis, Inc. reported a significant revenue decline and increased net loss for Q3 2025, leading management to express substantial doubt about its ability to continue as a going concern.
Delay expected
Worse than expected
Capital raise
NASDAQ
Aemetis, Inc. reported a narrower net loss in Q2 2025, driven by improved California Dairy RNG performance and reduced SG&A, despite significant revenue declines in other segments and ongoing liquidity concerns.
Delay expected
Worse than expected
Capital raise
NASDAQ
Aemetis, Inc. reports a net loss for Q1 2025 and expresses substantial doubt about its ability to continue as a going concern, while amending its Series A Preferred Unit Purchase Agreement to extend redemption deadline.
Worse than expected
Capital raise
Delay expected
NASDAQ
Aemetis Inc. saw revenue growth in Q3 2024, primarily driven by its biodiesel and renewable natural gas segments, but the company continues to experience net losses.
Worse than expected
Capital raise

Annual Reports (10-K)

NASDAQ
Aemetis, Inc.'s 2024 10-K filing reveals increased production across its segments but also highlights ongoing financial challenges and a net loss of $87.5 million.
Capital raise
Worse than expected
NASDAQ
Aemetis secures a limited waiver and amendment to its note purchase agreement, adjusting financial covenants and reaffirming its debt obligations.

Insider Trading (Form 4)

See all →
NASDAQ
Director Timothy Alan Simon reported the purchase of 10,000 shares of AEMETIS, Inc. common stock on June 10, 2026.
NASDAQ
Aemetis's Executive Vice President and CFO, Todd Waltz, acquired 200,000 stock options at an exercise price of $2.64, with a vesting schedule over three years.
NASDAQ
Aemetis, Inc. Executive Vice President Sanjeev Gupta was granted 200,000 stock options with an exercise price of $2.64, vesting quarterly over three years.
NASDAQ
Aemetis, Inc.'s EVP and General Counsel, James Michael Rockett, acquired 200,000 stock options at an exercise price of $2.64, vesting quarterly.
NASDAQ
Aemetis Director John R. Block was granted 10,000 shares of common stock as compensation for board service, effective March 19, 2026.
NASDAQ
Aemetis Executive Vice President Andrew B. Foster acquired options to purchase 200,000 shares of common stock at an exercise price of $2.64.

Proxy Statements (Def-14A)

NASDAQ
Aemetis, Inc. has announced its Annual Meeting of Stockholders will be held on May 20, 2026, to elect a director and ratify the appointment of its auditor.
NASDAQ
Aemetis, Inc. is holding a Special Meeting on February 18, 2026, to vote on proposals to decrease authorized preferred stock and increase authorized common stock.
Delay expected
Capital raise
NASDAQ
Aemetis, Inc. will hold its Annual Meeting of Stockholders on May 14, 2025, to vote on the election of directors, ratification of the auditor, and an advisory vote on executive compensation.
NASDAQ
Aemetis, Inc. is holding its annual stockholder meeting on May 29, 2024, to vote on the election of directors, ratification of the auditor, and amendments to the company's certificate of incorporation.

Schedule 13G - Passive Investments

NASDAQ
BlackRock, Inc. has reported a beneficial ownership of 5.6% in Aemetis Inc. as of June 30, 2026.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, reporting a reduction in its passive beneficial ownership stake in Aemetis, Inc. to 4.9% as of December 31, 2024.
Worse than expected